Cargando…
Treatment of Autoimmune Diabetes by Inhibiting the Initial Event
Recent papers have shown that the initial event in the pathogenesis of autoimmune type 1 diabetes (T1D) comprises sensing of molecular patterns released from apoptotic β-cells by innate immune receptors such as toll-like receptor (TLR). We have reported that apoptotic β-cells undergoing secondary ne...
Autor principal: | Lee, Myung-Shik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association of Immunologists
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3817300/ https://www.ncbi.nlm.nih.gov/pubmed/24198744 http://dx.doi.org/10.4110/in.2013.13.5.194 |
Ejemplares similares
-
Amelioration of Autoimmune Diabetes of NOD Mice by Immunomodulating Probiotics
por: Kim, Tae Kang, et al.
Publicado: (2020) -
Role of Autophagy in the Pathogenesis of Diabetes and Therapeutic Potential of Autophagy Modulators in the Treatment of Diabetes and Metabolic Syndrome
por: Oh, Soo-Jin, et al.
Publicado: (2022) -
Inhibition of Pyruvate Dehydrogenase in the Heart as an Initiating Event in the Development of Diabetic Cardiomyopathy
por: Elnwasany, Abdallah, et al.
Publicado: (2023) -
Role of Innate Immunity in the Pathogenesis of Type 1 and Type 2 Diabetes
por: Lee, Myung-Shik
Publicado: (2014) -
Role of Innate Immunity in Diabetes and Metabolism: Recent Progress in the Study of Inflammasomes
por: Lee, Myung-Shik
Publicado: (2011)